Palo Alto, CA, United States of America

G V Madhaven

This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: G V Madhaven. Retrieved from https://idiyas.com/inventor/g-v-madhaven

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: G V Madhaven: Innovator in Antiviral Compounds

Introduction

G V Madhaven is a notable inventor based in Palo Alto, California. She has made significant contributions to the field of antiviral agents through her innovative research and development.

Latest Patents

Madhaven holds a patent for "Purinyl or pyrimidinyl substituted hydroxycyclopentane compounds useful." This patent describes novel 4-substituted-5-hydroxymethyl-1,2-cyclopentanediols or 1-cyclopentanol substituted at the 3-position by various heterocyclic groups, which are useful as antiviral agents. Her work in this area showcases her commitment to advancing medical science.

Career Highlights

G V Madhaven has worked at Syntex (U.S.A.) Inc., where she has been involved in groundbreaking research. Her career reflects a dedication to innovation and the development of new therapeutic agents.

Collaborations

Madhaven has collaborated with esteemed colleagues such as Julien P Verheyden and John C Martin. These partnerships have further enhanced her research and contributions to the field.

Conclusion

G V Madhaven's work in developing antiviral compounds highlights her role as a significant inventor in the pharmaceutical industry. Her contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…